1128
Vol. 57, No. 10
Union Medical College. A voucher specimen has been deposited in the Insti-
tute of Medicinal Plant Development, Chinese Academy of Medical Sci-
ences and Peking Union Medical College (voucher No. TC-2003-10-08).
Extraction and Isolation The plant material (dry weight, 13.0 kg) was
extracted with 95% EtOH (100 lꢂ2) and 50% EtOH (100 lꢂ1) under reflux.
The EtOH extract (1.5 kg) was suspended in water, extracted with petrol
ester, CHCl3, n-BuOH successively. The CHCl3 part (220 g) was chro-
matographed on a silica gel column with a stepwise gradient mixture of
CHCl3–MeOH (9 : 1, 4 : 1, 3 : 1, 2 : 1, and 1 : 1; 4 l of each), and each fraction
was monitored by TLC, and combined to 10 fractions.
Fig. 3. Important NOE Correlations of 1
Fraction 6 was further chromatographed on a silica gel MPLC column
with gradient CHCl3–MeOH (100 : 0—90 : 10) as eluent, and further purified
with Sephadex LH-20 column to give 4 (22 mg) and 5 (39 mg). Fraction 7
was further chromatographed on an ODS column with gradient MeOH–H2O
(4 : 6—6 : 4) as eluent, and further purified with Sephadex LH-20 column to
give 1 (30 mg). Fraction 8 was recrystalized with 95% EtOH to give 3
(25 mg). Fraction 9 was separated by preparative HPLC using CH3CN–H2O
(25 : 75) to give 6 (11 mg) and 7 (21 mg). Fraction 10 was separated by
preparative HPLC using CH3CN–H2O (25 : 75) to give 2 (11 mg).
Compound 1: White plates, mp 224—226 °C (MeOH); [a]D25 ꢁ66.8°
(cꢃ0.10, CHCl3); CD (MeOH) lmax (De) 251.7 nm (ꢁ15.0); IR (film) nmax
1
3440 (OH), 1733 ((CꢃO), 1701, 1690 (a,b-unsaturated d-ketone); H- and
13C-NMR (CDCl3), see Table 1; HR-ESI-MS m/z: 773.2224 (Calcd for
C38H54O15Na, 773.3360).
Compound 2: White needle, mp 260—261 °C (MeOH); [a]D25 ꢀ93.6°
Fig. 4. Key HMBC Correlations Observed in 2
1
(cꢃ0.10, MeOH); IR (film) nmax 3440 (OH), 2934 (CH), 1635 (CꢃC); H-
and 13C-NMR (C5D5N), see Table 2; HR-ESI-MS m/z: 1053.5208 [MꢁNa]ꢁ
(Calcd for C51H82O21Na, 1053.5210).
anomeric protons and carbons of four monosaccharides (dH
4.90, d, Jꢃ7.8 Hz, dC 99.9; dH 5.24, d, Jꢃ7.8 Hz, dC 106.6;
dH 5.75, s, dC 103.2; dH 5.81, s, dC 102.6), suggested 2 to be
Acid Hydrolysis of 1 and 2 Compounds 1 and 2 (3 mg, each) were dis-
solved in 2 M CF3COOH (2 ml) and heated to 120 °C in a sealed tube for 2 h.
After extraction with CHCl3, the aqueous layer was concentrated to dryness
using N2 gas. The residue was dissolved in H2O (1 ml) and filtrated, which
was then analyzed by HPLC under the following conditions: column, Cos-
mosil sugar-D (4.6 mm i.d.ꢂ250 mm, 5 mm); solvent, MeCN–H2O (80 : 20);
flow rate, 1.0 ml/min; detection, ELSD and OR. Identification of D-glucose
for 1, L-rhamnose and D-glucose for 2 were carried out by comparison of
their retention time and optical rotation with those of authentic samples: tR
(min) 6.3 (L-rhamnose, negative optical rotation), 11.7 (D-glucose, positive
optical rotation).
a steroidal glycoside. By comparisons of the H- and 13C-
1
NMR data with those reported,3,9,10) the signals of C-24, C-
25, C-26, C-27 (dC 29.3, 30.6, 66.9, 17.3) revealed Me-27 in
an equatorial position rather than in axial position (dC 25.8,
26.0, 65.0, 16.1). Thus, the aglycone of 2 was deduced as
diosgenin ((25R)-spirost-5-en-3b-ol).9,11)
Results of acid hydrolysis gave only D-glucose and L-
rhamnose. In HMBC spectrum, correlations were observed
from dH 4.90 (H-1ꢄ) to dC 77.8 (C-3), from dH 5.81 (H-1ꢅ) to
dC 78.6 (C-2ꢄ), from dH 5.75 (H-1ꢆ) to dC 86.4 (C-3ꢄ), and
from dH 5.24 (H-1ꢅꢅ) to dC 84.6 (C-4ꢆ). By comparision its
NMR data with (25S)-spirost-5-en-3-yl-O-a-L-rhamnopy-
ranosyl-(1→2)-O-[O-b -D-glucopyranosyl-(1→4)-a -L-
rhamnopyranosyl-(1→3)]-b-D-glucopyranoside,3) 2 has the
same sugar sequences with the known one. Thus, 2 was iden-
tified as (25R)-spirost-5-en-3-yl-O-a-L-rhamnopyranosyl-
(1→2)-O-[O-b-D-glucopyranosyl-(1→4)-a-L-rhamnopyra-
nosyl-(1→3)]-b-D-glucopyranoside.
Acknowledgments The authors thank L. P. Shi of the Shanghai Institute
of Materia Medica, Chinese Academy of Sciences, China, for measurements
of NMR spectra.
References
1) Editorial Board of Zhong Hua Ben Cao of State Administration of
Traditional Chinese Medicine, “Zhong Hua Ben Cao,” Vol. VIII,
Shanghai Scientific and Technological Press, Shanghai, 1999, pp.
221—222.
2) Yokosuka A., Mimaki Y., Sakagami H., Sashida Y., J. Nat. Prod., 65,
283—289 (2002).
3) Yokosuka A., Mimaki Y., Sashida Y., Phytochemistry, 61, 73—78
(2002).
Experimental
4) Yokosuka A., Mimaki Y., Sashida Y., J. Nat. Prod., 65, 1293—1298
(2002).
5) Padma S. V., Jyoti S., Kresimir M., Phytochemistry Lett., 2, 67—71
(2009).
6) Yokosuka A., Mimaki Y., Sakagami H., Sashida, Y., J. Nat. Prod., 66,
876—878 (2003).
7) Huang Y., Liu J. K., Mulbauer A., Henkel T., Helv. Chim. Acta, 85,
2553—2558 (2002).
General Optical rotation was measured on a JASCO DIP-360 digital
polarimeter (lꢃ5 cm). UV spectra were measured on a Hitachi 200 spec-
trophotometer; IR spectra were recorded on a Perkin Elmer 781 infrared
spectrophotometer; CD spectra were recorded with a Jasco J-720 spectropo-
larimeter; 1H-NMR (600 MHz), 13C-NMR (125 MHz), and 2D-NMR spectra
were recorded on a Inova-600 spectrometer. ESI-MS and HR-ESI-MS were
recorded on a JMS-700 mass spectrometer; Column chromatography was
performed on silica gel 60 (Merck, 70—230 mesh), MPLC was performed
on a BÜCHI B-688 type instrument, and preparative HPLC was performed
using an ODS column (YMC-ODS, 20 mm i.d.ꢂ250 mm).
8) Singh S. B., Thakur R. S., Schulten H.-R., Phytochemistry, 21, 2925—
2929 (1982).
9) Mimaki Y., Watana K., Ando Y., J. Nat. Prod., 64, 17—22 (2001).
Plant Material The rhizomes of T. chantrieri were collected in Jing 10) Yu D. Q., Yang J. S., “Analytical Chemistry Manual,” Chemical Indus-
Hong City, Yunnan Province, People’s Republic of China, in October 2003,
try Press, Beijing, 1999, p. 897.
and identified by Prof. Zai-Lin Li, Yunnan Branch of Institute of Medicinal 11) Li M., Han X. W., Liu X. M., Yu B., Xing G. W., Hui Y. Z., Bao X.,
Plant Development, Chinese Academy of Medical Sciences and Peking
Magnetic Resonance In Chemistry, 40, 789—792 (2002).